K Number
K994097
Device Name
MEDAMICUS EPIDURAL INTRODUCER
Manufacturer
Date Cleared
2000-03-01

(89 days)

Product Code
Regulation Number
882.5880
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
For percutaneous introduction, manipulation, and removal of epidural stimulation leads.
Device Description
The MedAmicus Epidural Introducer is intended to be used in the same manner as the ANS (Neuromed) Introde INT-8 cleared by the FDA under K930242 and in a similar manner to the Coaxial Dilator manufactured by MedAmicus, Inc. and cleared by the FDA under K990705.
More Information

Not Found

No
The summary describes a mechanical introducer device and makes no mention of AI, ML, image processing, or any data-driven performance metrics typically associated with AI/ML devices.

No
The device is described as an epidural introducer for stimulation leads, which are used to deliver electrical stimulation, but the introducer itself is a physical tool for placement and removal, not for delivering therapy.

No
The device is described as an epidural introducer used for the percutaneous introduction, manipulation, and removal of epidural stimulation leads. This is a procedural tool, not a device that identifies or characterizes a disease or condition.

No

The device description explicitly states it is an "Epidural Introducer," which is a physical medical device used for introducing leads. The predicate devices are also physical introducers and dilators. There is no mention of software as the primary component or function.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is "For percutaneous introduction, manipulation, and removal of epidural stimulation leads." This describes a surgical or interventional procedure performed directly on a patient, not a test performed on a sample of bodily fluid or tissue outside the body.
  • Device Description: The description talks about introducing and manipulating leads, which are physical components used in a medical procedure.
  • Lack of IVD Indicators: There is no mention of analyzing samples, detecting substances, or providing diagnostic information based on laboratory tests.

IVD devices are specifically designed to perform tests on samples (like blood, urine, tissue) to diagnose diseases or conditions. This device is a tool used in a medical procedure.

N/A

Intended Use / Indications for Use

For percutaneous introduction, manipulation, and removal of epidural stimulation leads.

Product codes

GZB

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K990705, K930242

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 882.5880 Implanted spinal cord stimulator for pain relief.

(a)
Identification. An implanted spinal cord stimulator for pain relief is a device that is used to stimulate electrically a patient's spinal cord to relieve severe intractable pain. The stimulator consists of an implanted receiver with electrodes that are placed on the patient's spinal cord and an external transmitter for transmitting the stimulating pulses across the patient's skin to the implanted receiver.(b)
Classification. Class II (performance standards).

0

CONFIDENTIAL

Medamicus Inc.

510 (k) Submission

Epidural Introducer

MAR - 1 2000

510(k) Summary

K 994097

MedAmicus Epidural Introducer

Date of Preparation: October 29, 1999

General Information

Trade NameMedAmicus Epidural Introducer
Classification NameIntroducer, Percutaneous §870.1340
Common NamePercutaneous Introducer
SubmitterMedAmicus, Inc.
15301 Highway 55 West
Minneapolis, MN 55447
ContactDennis S. Madison
Vice President, Quality
Assurance/Regulatory Affairs
612-559-2613, Fax: 612-559-7548

Predicate Devices

Coaxial Dilator from MedAmicus, Inc. (K990705) Introde INT-8 from ANS (Neuromed), Inc. (K930242) ·

Device Description Information

Intended Use

The MedAmicus Epidural Introducer is intended to be used in the same manner as the ANS (Neuromed) Introde INT-8 cleared by the FDA under K930242 and in a similar manner to the Coaxial Dilator manufactured by MedAmicus, Inc. and cleared by the FDA under K990705. The intended use of these introducers is for percutaneous introduction, manipulation, and removal of epidural stimulation leads.

Conclusion

MedAmicus believes the MedAmicus Epidural Introducer is safe and effective based on substantial equivalence to the predicate MedAmicus and ANS Introducer Sheaths. The intended use, materials, labeling, method of operation and manufacturing methods are substantially equivalent.

1

Image /page/1/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of an eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAR - 1 2000

Mr. Dennis S. Madison Vice President, Quality Assurance and Regulatory Affairs MedAmicus. Inc. 15301 Highway 55 West Minneapolis, Minnesota 55447

K994097 Re:

Trade Name: MedAmicus Epidural Introducer Regulatory Class: II Product Code: GZB Dated: November 29, 1999 Received: December 3, 1999

Dear Mr. Madison:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

2

Page 2 – Mr. Dennis S. Madison

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Theodore Sayre

So- James E. Dillard III Acting Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

Medamicus Inc.

510 (k) Submission

Epidural Introducer

Statement of Indications for Use

K 994097

For percutaneous introduction, manipulation, and removal of epidural stimulation leads.

Contraindications

None

Russell Page

(Division Sign-Off) Division of General Restorative Devices 510(k) Number -16954097

Prescription Use
(Per 21 CFR 801.109)